Jill Ford

1.3k total citations
17 papers, 1.0k citations indexed

About

Jill Ford is a scholar working on Immunology, Physiology and Oncology. According to data from OpenAlex, Jill Ford has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 4 papers in Physiology and 3 papers in Oncology. Recurrent topics in Jill Ford's work include Inflammation biomarkers and pathways (5 papers), Asthma and respiratory diseases (4 papers) and Immune Cell Function and Interaction (4 papers). Jill Ford is often cited by papers focused on Inflammation biomarkers and pathways (5 papers), Asthma and respiratory diseases (4 papers) and Immune Cell Function and Interaction (4 papers). Jill Ford collaborates with scholars based in United States, France and Germany. Jill Ford's co-authors include Daniel W. McVicar, Daniel H. Conrad, Jamie Sturgill, David R. Gibb, Deborah J. Fowell, Alexander F. Rosenberg, Shoshana D. Katzman, Christopher A. Lazarski, Roy A. Black and Gisela Weskamp and has published in prestigious journals such as Nature Immunology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jill Ford

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jill Ford United States	12	690	160	155	150	145	17	1.0k
Jon D. Laman Netherlands	12	1.1k 1.5×	135 0.8×	152 1.0×	191 1.3×	222 1.5×	14	1.6k
Florencio Varas Spain	14	546 0.8×	129 0.8×	60 0.4×	447 3.0×	110 0.8×	17	1.2k
Catriona A. Wagner United States	18	349 0.5×	46 0.3×	125 0.8×	190 1.3×	107 0.7×	24	1.2k
J A Carlino United States	13	1.0k 1.5×	103 0.6×	69 0.4×	314 2.1×	294 2.0×	22	1.5k
Pamela J. Daffern United States	12	512 0.7×	153 1.0×	287 1.9×	128 0.9×	60 0.4×	13	953
Heiko Hawlisch Germany	13	696 1.0×	71 0.4×	101 0.7×	197 1.3×	34 0.2×	16	1.0k
Christopher Piercy United States	6	551 0.8×	118 0.7×	36 0.2×	176 1.2×	113 0.8×	6	1.1k
Amerigo Santoro Italy	12	463 0.7×	68 0.4×	178 1.1×	153 1.0×	161 1.1×	15	1.0k
Thomas M. Yankee United States	16	486 0.7×	66 0.4×	100 0.6×	233 1.6×	126 0.9×	35	897
Gerard F. Vitti Australia	7	449 0.7×	115 0.7×	63 0.4×	171 1.1×	145 1.0×	7	946

Countries citing papers authored by Jill Ford

Since Specialization

Citations

This map shows the geographic impact of Jill Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Ford more than expected).

Fields of papers citing papers by Jill Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Ford. The network helps show where Jill Ford may publish in the future.

Co-authorship network of co-authors of Jill Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Ford. A scholar is included among the top collaborators of Jill Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Ford. Jill Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ford, Jill, Marieli Gonzalez-Cotto, Alexander W. Macfarlane, et al.. (2022). Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma. Frontiers in Oncology. 11. 662723–662723. 30 indexed citations

Koenig, Kristin L, Ying Huang, Seema A. Bhat, et al.. (2020). Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists. Blood Advances. 4(19). 4860–4863. 14 indexed citations

Ford, Jill, Angela Hughson, Kihong Lim, et al.. (2019). CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection. Frontiers in Immunology. 9. 3063–3063. 31 indexed citations

Ford, Jill, et al.. (2016). Regulatory T Cell Numbers in Inflamed Skin Are Controlled by Local Inflammatory Cues That Upregulate CD25 and Facilitate Antigen-Driven Local Proliferation. The Journal of Immunology. 197(6). 2208–2218. 5 indexed citations

McVicar, Daniel W., O. M. Zack Howard, Laura Quigley, et al.. (2014). The myeloid receptor TREM2 exacerbates DSS-induced colitis and promotes colitis-associated cancer (TUM4P.916). The Journal of Immunology. 192(Supplement_1). 138.17–138.17. 1 indexed citations

Lazarski, Christopher A., Jill Ford, Shoshana D. Katzman, Alexander F. Rosenberg, & Deborah J. Fowell. (2013). IL-4 Attenuates Th1-Associated Chemokine Expression and Th1 Trafficking to Inflamed Tissues and Limits Pathogen Clearance. PLoS ONE. 8(8). e71949–e71949. 62 indexed citations

Derive, Marc, Youcef Bouazza, N. Sennoun, et al.. (2012). Soluble Trem-like Transcript-1 Regulates Leukocyte Activation and Controls Microbial Sepsis. The Journal of Immunology. 188(11). 5585–5592. 92 indexed citations

Mathews, Joel, Jill Ford, Sarah K. Norton, et al.. (2011). A potential new target for asthma therapy: A Disintegrin and Metalloprotease 10 (ADAM10) involvement in murine experimental asthma. Allergy. 66(9). 1193–1200. 40 indexed citations

Ford, Jill, O. M. Zack Howard, Jeff Subleski, et al.. (2010). Enhanced Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) and Soluble TREM-1 Levels in the Myeloid Cells of Tumor-Bearing Mice and Patients with Renal Cell Carcinoma (100.8). The Journal of Immunology. 184(Supplement_1). 100.8–100.8. 1 indexed citations

10.

Orr, Selinda J., Laura Quigley, Tim Hon Man Chan, et al.. (2010). Implications for Gene Therapy-Limiting Expression of IL-2Rγc Delineate Differences in Signaling Thresholds Required for Lymphocyte Development and Maintenance. The Journal of Immunology. 185(3). 1393–1403. 9 indexed citations

11.

Ford, Jill & Daniel W. McVicar. (2009). TREM and TREM-like receptors in inflammation and disease. Current Opinion in Immunology. 21(1). 38–46. 377 indexed citations

12.

Norton, Sarah K., Brian Barnstein, Daniel P. Bailey, et al.. (2008). IL-10 Suppresses Mast Cell IgE Receptor Expression and Signaling In Vitro and In Vivo. The Journal of Immunology. 180(5). 2848–2854. 87 indexed citations

13.

Ford, Jill, Jamie Sturgill, & Daniel H. Conrad. (2008). 129/SvJ mice have mutated CD23 and hyper IgE. Cellular Immunology. 254(2). 124–134. 11 indexed citations

14.

Conrad, Daniel H., Jill Ford, Jamie Sturgill, & David R. Gibb. (2007). CD23: An overlooked regulator of allergic disease. Current Allergy and Asthma Reports. 7(5). 331–337. 71 indexed citations

15.

Weskamp, Gisela, Jill Ford, Jamie Sturgill, et al.. (2006). ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nature Immunology. 7(12). 1293–1298. 162 indexed citations

16.

Ford, Jill, et al.. (2006). In vivo murine CD23 destabilization enhances CD23 shedding and IgE synthesis. Cellular Immunology. 243(2). 107–117. 20 indexed citations

17.

Jiao, Jin‐an, et al.. (2004). Application of Chemically-Stable Immunoglobulin-Selective Sorbents: Capture and Purification of Antibodies with Resolution of Aggregate. BioProcessing Journal. 3(5). 53–62. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact